The Drug Eluting Stents Center

Filter Your Results

 

News

 

The State of Peripheral Drug‑Eluting Technologies

Michael R. Jaff, DO

September 2017— When comparing the myriad options available for the treatment of patients with peripheral artery disease (PAD) today compared to just 1 decade ago, it is a testimony to ph…

Interim Results From the Muenster Postmarket All-Comers Registry

Theodosios Bisdas, MD, PhD

September 2017—A look at the latest data on use of the Eluvia drug-eluting stent in challenging SFA lesions.

Economic Analysis Supporting the Use of Drug-Eluting Technologies in the Femoropopliteal Artery

Konstantinos Katsanos, MSc, MD, PhD, EBIR

September 2017—These evolving modern therapies are showing promise in reducing health care costs while offering better outcomes.

Experience With Drug-Eluting Technologies in BTK Interventions

Hans van Overhagen, MD, PhD, EBIR

September 2017—Promising results for drug-eluting stent use in CLI patients with lesions below the knee.

What’s Next in Drug-Eluting SFA Technology?

With Juan F. Granada, MD, FACC

September 2017—Juan Granada, MD, discusses potential next-generation advancements in drugs, delivery methods, and study.

Ask the Experts: Perfect Pairing: Which Stent Properties Are the Best Match for Drug-Coated Balloons?

With Stavros Spiliopoulos, MD, PhD, EBIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Mark W. Burket, MD; and Thomas Zeller, MD

September 2017—Experts weigh in on properties of available stent technology and which combinations could be used to improve femoropopliteal disease outcomes.

iVascular's Angiolite BTK Sirolimus-Eluting Stent Launched in Europe

July 18, 2017 -- iVascular announced the European launch of its Angiolite BTK sirolimus-eluting stent. The device has received CE Mark approval for treating chronic and acute …

VascuFlex® Multi-LOC: Spot Stenting With SeQuent® Please OTW DCB

Klaus Amendt, MD, and Ralf Langhoff, MD

May 2017—Realizing the concept of leave-less-behind after DCB angioplasty in atherosclerotic lesions of the femoropopliteal artery.

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.